The Utility of the Combined Use of 123I-FP-CIT and 123I-MIBG Myocardial Scintigraphy in Differentiating Parkinson's Disease from Other Parkinsonian Syndromes
- PMID: 29946218
- PMCID: PMC6015794
- DOI: 10.33160/yam.2018.06.004
The Utility of the Combined Use of 123I-FP-CIT and 123I-MIBG Myocardial Scintigraphy in Differentiating Parkinson's Disease from Other Parkinsonian Syndromes
Abstract
Background: 123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy and 123I-FP-CIT dopamine transporter single photon emission computed tomography (DAT-SPECT) provide specific information that distinguish Parkinson's disease (PD) from parkinsonian syndromes other than PD (non-PD), including atypical parkinsonian disorder (APD) and non-PD other than APD (nPD-nAPD). The purpose of this study was to determine whether combining DAT-SPECT and MIBG myocardial scintigraphy using multiparametric scoring system (MSS) could improve diagnostic test accuracy in discriminating PD from APD or discriminating PD from nPD-nAPD.
Methods: A total of 52 patients, including 36 PD, eight APD and eight nPD-nAPD, underwent both MIBG myocardial scintigraphy and DAT-SPECT, were evaluated. The heart-to-mediastinum (H/M) ratios (early and delayed), washout-rate (WR), the average (Ave) and asymmetry index (AI) of specific binding ratio (SBR) were calculated. Cutoff values were determined, using ROC analysis, for discriminating PD from APD and for discriminating PD from nPD-nAPD, on five parameters. All cases were scored as either 1 (PD) or 0 (nPD-nAPD or APD) for each parameter according to its threshold in each discrimination. These individual scores were summed for each case, yielding a combined score to obtain a cutoff value for the MSS in each discrimination.
Results: For discriminating PD from nPD-nAPD, the highest accuracy was 80% at a cutoff value of 19% for the WR and a cut off value of 2 improved diagnostic accuracy to 84% for MSS. For discriminating PD from APD, the highest accuracy was 86% at a cutoff value of 2.8 for the H/M ratio (late) and a cut off value of 2 showed diagnostic accuracy of 86% for MSS.
Conclusion: A MSS has comparable or better accuracy compared to each parameter of MIBG myocardial scintigraphy and DAT-SPECT in distinguishing PD from nPD-nAPD or distinguishing PD from APD.
Keywords: 123I-FP-CIT; 123I-MIBG; Parkinson’s disease; combined analysis.
Figures


Similar articles
-
The utility of the combined use of 123I-FP-CIT SPECT and neuromelanin MRI in differentiating Parkinson's disease from other parkinsonian syndromes.Acta Radiol. 2019 Feb;60(2):230-238. doi: 10.1177/0284185118778871. Epub 2018 May 27. Acta Radiol. 2019. PMID: 29804474
-
The utility of the combination of a SPECT study with [123I]-FP-CIT of dopamine transporters and [123I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes.Nucl Med Commun. 2017 Jun;38(6):487-492. doi: 10.1097/MNM.0000000000000674. Nucl Med Commun. 2017. PMID: 28410288 Free PMC article.
-
Combined use of dopamine transporter imaging (DAT-SPECT) and 123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy for diagnosing Parkinson's disease.J Neurol Sci. 2017 Apr 15;375:80-85. doi: 10.1016/j.jns.2017.01.042. Epub 2017 Jan 14. J Neurol Sci. 2017. PMID: 28320195
-
Cardiac 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy in Parkinson's Disease: A Comprehensive Review.Brain Sci. 2023 Oct 18;13(10):1471. doi: 10.3390/brainsci13101471. Brain Sci. 2023. PMID: 37891838 Free PMC article. Review.
-
MIBG scintigraphy in differential diagnosis of Parkinsonism: a meta-analysis.Clin Auton Res. 2012 Feb;22(1):43-55. doi: 10.1007/s10286-011-0135-5. Epub 2011 Jul 27. Clin Auton Res. 2012. PMID: 21792729 Review.
Cited by
-
MRI multiparametric scoring system for pial blood supply of intracranial meningiomas.Acta Radiol Open. 2022 Apr 8;11(4):20584601221091208. doi: 10.1177/20584601221091208. eCollection 2022 Apr. Acta Radiol Open. 2022. PMID: 35425642 Free PMC article.
-
A diagnostic strategy for Parkinsonian syndromes using quantitative indices of DAT SPECT and MIBG scintigraphy: an investigation using the classification and regression tree analysis.Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):1833-1841. doi: 10.1007/s00259-020-05168-0. Epub 2021 Jan 3. Eur J Nucl Med Mol Imaging. 2021. PMID: 33392714 Free PMC article.
References
-
- Nikolaus S, Antke C, Kley K, Poeppel TD, Hautzel H, Schmidt D, et al. Investigating the dopaminergic synapse in vivo. I. Molecular imaging studies in humans. Rev Neurosci. 2007;18:439-72. - PubMed
-
- Nikolaus S, Antke C, Müller HW. In vivo imaging of synaptic function in the central nervous system: I. Movement disorders and dementia. Behav Brain Res. 2009;204:1-31. - PubMed
-
- la Fougère C, Pöpperl G, Levin J, Wängler B, Böning G, Uebleis C, et al. The value of the dopamine D2/3 receptor ligand 18F-desmethoxyfallypride for the differentiation of idiopathic and nonidiopathic parkinsonian syndromes. J Nucl Med. 2010;51:581-7. - PubMed
-
- Kägi G, Bhatia KP, Tolosa E. The role of DAT-SPECT in movement disorders. J Neurol Neurosurg Psychiatry. 2010;81:5-12. - PubMed
-
- Wieland DM, Brown LE, Rogers WL, Worthington KC, Wu JL, Clinthorne NH, et al. Myocardial imaging with a radioiodinated norepinephrine storage analog. J Nucl Med. 1981;22:22-31. - PubMed
LinkOut - more resources
Full Text Sources